- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01222429
Practice Based Nutrition Intervention
Practice-Based Nutrition Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Specific Aim 1 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) improves glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in a within-group analysis.
Specific Aim 2 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) is more effective than standard nutrition care for improving glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in individuals with type 2 diabetes
Specific Aim 3 tests the hypothesis that a low-fat vegan diet is sustainable among individuals with type 2 diabetes for a 20-week period, with weekly classes, and in a follow-up period of one year with limited professional support.
Specific Aim 4 tests the hypothesis that a low-fat vegan diet has an acceptability that is comparable to that of standard nutrition care among individuals with type 2 diabetes.
Specific Aim 5 tests the hypothesis that the effects of the dietary interventions on A1c and body weight are reduced in individuals with the A1 allele of the Taq1A and Taq1B polymorphism
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months
- male or female
- A1c between 6.5% and 10.5%
- age at least 18 years
- ability and willingness to participate in all components of the study
- willingness to be assigned to either a low-fat, vegan diet or to standard nutrition care
- diabetes medications unchanged for 1 month prior to volunteering for the study
- patient of Dr. Mark Sklar
Exclusion Criteria:
- body mass index >45 kg/m2
- alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
- pregnancy or plans to become pregnant
- history of severe mental illness (with current unstable status)
- likely to be disruptive in group sessions (as determined by research staff)
- Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss)
- unstable medical status
- already following a low-fat, vegetarian diet
- an inordinate fear of blood draws
- inability to maintain current medication regimen
- lack of English fluency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: diet following American Diabetes Association guidelines
Participants will follow diets based on ADA guidelines.
This group will also receive weekly nutrition classes.
|
participants will be given instruction on the ADA guidelines for diabetes, and will follow an individualized plan based on these guidelines
|
Experimental: vegan diet
Participants in the intervention group will follow a low-fat, vegan diet for 20 weeks, and will attend nutrition classes in the form of a weekly support group.
|
Intervention group participants will follow a low-fat vegan diet and will receive instruction on this diet through the course of the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
hemoglobin A1C (diabetes management)
Time Frame: assessment at baseline (0 weeks)
|
assessment at baseline (0 weeks)
|
hemoglobin A1C (diabetes management)
Time Frame: assessment at 10 weeks
|
assessment at 10 weeks
|
hemoglobin A1C (diabetes management)
Time Frame: assessment at 20 weeks
|
assessment at 20 weeks
|
hemoglobin A1C (diabetes management)
Time Frame: assessment at one-year follow-up
|
assessment at one-year follow-up
|
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at baseline (0 weeks)
|
assessment at baseline (0 weeks)
|
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at 10 weeks
|
assessment at 10 weeks
|
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assesment at 20 weeks
|
assesment at 20 weeks
|
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at one-year follow-up
|
assessment at one-year follow-up
|
body weight
Time Frame: assessment at baseline (0 weeks)
|
assessment at baseline (0 weeks)
|
body weight
Time Frame: assessment at 10 weeks
|
assessment at 10 weeks
|
body weight
Time Frame: assessment at 20 weeks
|
assessment at 20 weeks
|
body weight
Time Frame: assessment at one-year follow-up
|
assessment at one-year follow-up
|
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at baseline (0 weeks)
|
assessment at baseline (0 weeks)
|
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at 10 weeks
|
assessment at 10 weeks
|
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at 20 weeks
|
assessment at 20 weeks
|
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at one-year follow-up
|
assessment at one-year follow-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Neal D Barnard, MD, Washington Center for Clinical Research
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PBNI-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on diet following ADA guidelines
-
Physicians Committee for Responsible MedicineCompleted
-
The University of Texas Health Science Center,...Not yet recruitingFetal Growth RetardationUnited States
-
Institute for Clinical and Experimental MedicineCompletedInsulin ResistanceCzech Republic
-
Hospital de Clinicas de Porto AlegreTerminated
-
Yi YangWuzhou Red Cross Hospital; General Hospital of Shenyang Military Region; Chinese... and other collaboratorsRecruiting
-
Hadassah Medical OrganizationCompletedObese Type 2 Diabetic Patients
-
Morehouse School of MedicineEmory UniversityRecruiting
-
University of Massachusetts, WorcesterCompletedLow-GI Dietary Education | ADA Dietary EducationUnited States
-
Physicians Committee for Responsible MedicineGeorge Washington UniversitySuspendedDiabetes Mellitus, Type 2United States